Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Desert Gold Report Results from 3,900 Meter Phase 2 Exploration Drill Program (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Aion Therapeutic Inc ANTCF


Primary Symbol: C.AION

Aion Therapeutic Inc is in the business of research and development, treatment, data mining and state-of-the-art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for... see more

CSE:AION - Post Discussion

Aion Therapeutic Inc > Recent interview Dec 15
View:
Post by nightowl21 on Dec 17, 2021 1:26pm

Recent interview Dec 15

https://youtu.be/lubo581BlHc
Comment by nightowl21 on Dec 18, 2021 4:15pm
Informative update....about clinical trails!  Presume it includes the Aion mushroom protocal ...Dr Barnhill has ownership in both companies and executive positions! I think these press updates by “proactive “....which I think are under the KCSA umbrella...should represent both companies! No mention of AION.  I presume we are still engaged with KCSA and paying $15,000 a month....maybe ...more  
Comment by DrJonnyFever on Dec 21, 2021 1:16pm
Makes me wary that they only mentioned Appolon. Aion owns AI Jamaica but I don't know how all of this is rolled togther - sounds like one big clusterfu*k. So far there was one seemingly worthwhile release that everyone sold on...
Comment by nightowl21 on Dec 21, 2021 7:32pm
Sorry not a fair comment to assess what is going on between Aion and Apollon with  this type of one liner! what they are doing in Jamaica is huge! Dr Harnhill is involved on both sides ie Aion and Apollon...the important thing to understand is this work and clinical trials on Breast Cancer are real....Aion focus is mainly related to Mushrooms side...but we are part of the trials...we also ...more  
Aion Therapeutic Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities